PLASMA EXUDATION AND SOLUTE ABSORPTION ACROSS THE AIRWAY MUCOSA

被引:25
作者
GREIFF, L
ERJEFALT, I
SVENSSON, C
WOLLMER, P
ALKNER, U
ANDERSSON, M
PERSSON, CGA
机构
[1] UNIV LUND HOSP,DEPT CLIN PHARMACOL,S-22185 LUND,SWEDEN
[2] UNIV LUND HOSP,DEPT CLIN PHYSIOL,S-22185 LUND,SWEDEN
[3] ASTRA DRACO,DEPT BIOANAL,LUND,SWEDEN
来源
CLINICAL PHYSIOLOGY | 1993年 / 13卷 / 03期
关键词
BARRIER; DEFENSE; EPITHELIUM; INFLAMMATION;
D O I
10.1111/j.1475-097X.1993.tb00322.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The airway mucosa responds to inflammatory provocations with bulk exudation of plasma into the airway tissue (vascular exudation) and lumen (mucosal exudation). The intensity and time course of the exudative response can be relevantly examined by sampling and analysing airway surface liquids, because the luminal entry of plasma proteins/tracers promptly and quantitatively reflects the exudative response of the airways. The process of mucosal exudation of plasma is a prominent feature of airway inflammation and has been demonstrated in rhinitis, asthma, and bronchitis. Inflammatory mediators and allergen produce mucosal exudation of plasma into the airway lumen (outward permeability) whereas the solute absorption across the mucosa (inward permeability) is unaffected. Hence, in contrast to current views, we have demonstrated that in airway inflammation the solute absorption across the airway mucosa is not increased. The findings suggest the plasma exudation response also as a first line respiratory mucosal defence, allowing potent plasma protein systems to appear on an airway mucosa functionally intact as a barrier toward undue luminal material. Our data on plasma exudation and solute absorption across the mucosa of upper and lower airways further suggest the human nasal airways as a model relevant also for the tracheobronchial airways.
引用
收藏
页码:219 / 233
页数:15
相关论文
共 97 条
[1]  
ADELROTH E, 1990, THESIS U UMEA SWEDEN
[2]  
ALKNER U, 1991, J ALLERGY CLIN IMMUN, V87, pA217
[3]   OBJECTIVE MONITORING OF THE ALLERGIC INFLAMMATORY RESPONSE OF THE NASAL-MUCOSA IN PATIENTS WITH HAY-FEVER DURING NATURAL ALLERGEN EXPOSURE [J].
ANDERSSON, M ;
SVENSSON, C ;
ANDERSSON, P ;
PIPKORN, U .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (04) :911-914
[4]  
Arnold J., 1875, VIRCHOWS ARCH PATHOL, V62, P487
[5]  
BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289
[6]  
BASCOM R, 1988, AM REV RESPIR DIS, V137, pA375
[7]   INFLUX OF KININOGENS INTO NASAL SECRETIONS AFTER ANTIGEN CHALLENGE OF ALLERGIC INDIVIDUALS [J].
BAUMGARTEN, CR ;
TOGIAS, AG ;
NACLERIO, RM ;
LICHTENSTEIN, LM ;
NORMAN, PS ;
PROUD, D .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :191-197
[8]  
BECKER CG, 1969, AM J PATHOL, V55, P1
[9]  
BECKER CG, 1973, AM J PATHOL, V71, P1
[10]   EFFECT OF LEUKOTRIENE D4 ON NASAL MUCOSAL BLOOD-FLOW, NASAL AIRWAY-RESISTANCE AND NASAL SECRETION IN HUMANS [J].
BISGAARD, H ;
OLSSON, P ;
BENDE, M .
CLINICAL ALLERGY, 1986, 16 (04) :289-297